In Honor of National Breast Cancer Awareness Month and to Launch Initiative to Increase Awareness of Breast Cancer Screening and Fund Mammograms for
Underserved Women

BEDFORD, Mass., (September 28, 2009) - Hologic, Inc. (Hologic or the Company)
(NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium
diagnostics, medical imaging systems and surgical products dedicated to serving the
healthcare needs of women, today announced that Jack Cumming, Hologic Chairman and
CEO, will preside over the NASDAQ opening bell ceremony in New York City on
Thursday, October 1, 2009 at 9:30 a.m. (EST) for the fourth consecutive year to honor
the National Breast Cancer Awareness Month and to kick off Hologic's "Promise to Me"
campaign. The initiative is focused on increasing awareness of the importance of breast
cancer screening and Hologic's funding of mammograms for underserved women.

The American Cancer Society estimates more than 240,000 new cases of breast cancer
are diagnosed in the U.S. each year, with one of eight women being inflicted with this
deadly disease in her lifetime. "These statistics are overwhelming and we remain deeply
committed to helping women worldwide who are afflicted by this dreadful disease," said
Mr. Cumming. "Breast cancer screening programs and technologies, such as digital
mammography, have gone a long way toward decreasing death rates from breast cancer
and we will continue to do so not only with our current technology, but with the
introduction of new technologies such as our 3-D Selenia® Dimensions™ digital
tomosynthesis system."

Hologic is the worldwide leader in digital mammography systems with over 5,000
Selenia systems shipped. Digital mammography has set a new standard for providing the
earliest detection of breast cancer and Hologic is proud to be the preferred system of
choice around the world.

The focus of the Promise to Me campaign is to empower women to take ownership of
their health, starting with scheduling an annual mammogram. Program details will be
fully available on October 1, 2009, at www.promisetome.com. Through this initiative,
Hologic has committed to support women who are unable to afford mammograms,

and the Company has done so through a partnership with Remote Area Medical (RAM), a
non-profit, volunteer organization dedicated to bringing healthcare services to
underserved populations in remote areas in the U.S. and abroad.

"Hologic's focus and concentration on breast cancer is unparalleled," Mr. Cumming said.
"No other major healthcare company devotes a higher percentage of its resources to the
development and deployment of screening, diagnostic and therapeutic technologies to
meet the diverse challenges of this disease. As a result, breast surgeons, radiation
oncologists, and related healthcare professionals have come to rely on Hologic's
continued advancements in digital mammography, biopsy technologies, and radiationfocused
breast conservation therapy. Early detection can significantly improve a woman's
chance of surviving breast cancer and we remain passionately committed to improving
women's healthcare by providing a comprehensive portfolio of tools and innovations to
aid in early detection. It is our hope that increased awareness will encourage more
women to include screening mammography as part of their routine medical care."

To view the NASDAQ opening bell ceremony on October 1st, 2009, visit
www.nasdaq.com/reference/marketsite_about.stm beginning at 9:15 a.m. (EST). Viewers
must have Windows Media Player to view the web cam. Scroll to the bottom of the page
under the heading MarketSite Live Web cam and click on Windows Media Player. The
Web cam is live only and is not archived. Jack Cumming's opening remarks will also be
available on the investor relations page of the Company's website at
www.hologic.com/investor.

About Hologic
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics
products, medical imaging systems and surgical products dedicated to serving the
healthcare needs of women. Hologic's core business units are focused on breast health,
diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite
of technologies with products for mammography and breast biopsy, radiation treatment
for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia,
permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini Carm
for extremity imaging and molecular diagnostic products including HPV and
reagents for a variety of DNA and RNA analysis applications.

Forward Looking Statement Disclaimer
This News Release may contain forward-looking information that involves risks and
uncertainties, including statements about the use of digital mammography and digital
breast tomosynthesis. There can be no assurance that these systems will achieve the
benefits described herein and that such benefits will be replicated in any particular
manner with respect to an individual patient as the actual effects of the use of these
systems can only be determined on a case-by-case basis depending on the particular
circumstances of the procedure and patient in question. Hologic expressly disclaims any
obligation or undertaking to release publicly any updates or revisions to the data or
statements presented herein to reflect any change in the Company's expectations or any
change in events, conditions or circumstances on which any such data or statements are
based. Certain factors that could adversely affect the Company's business and prospects
are described in Hologic filings with the Securities and Exchange Commission.

Hologic, Selenia, and Dimensions are trademarks and/or registered trademarks of
Hologic, Inc., and/or its subsidiaries in the United States and/or other countries.